Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2008
11/13/2008US20080279823 Modified cytokine for use in tredatment and prevention of autoimmune, cell proliferative targeting and infectious disorders
11/13/2008US20080279817 Treatment of Autoimmune Diseases and Allograft Rejection with IL-21
11/13/2008US20080279808 2,3,4,5-Tetrahydroxy-6-Sulfooxy Hexanoic Acid, Pharmaceutically Acceptable Salts and Equilibrium Forms Thereof, Processes for Their Preparation, Pharmaceutical Compositions Comprising Such Compounds and Their Medical Use
11/13/2008DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use
11/13/2008DE102007022007A1 Neuartike Pharmazeutika, Verfahren zu ihrer Herstellung und ihre Verwendung in der Prophylaxe und Therapie von ZNS-Erkrankungen und Diabetes Neuartike pharmaceuticals, to processes for their preparation and their use in the prophylaxis and treatment of CNS disorders and diabetes
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2688187A1 Method of treament using fused aromatic compounds having anti-diabetic activity
11/13/2008CA2685568A1 Methods of modulating cellular homeostatic pathways and cellular survival
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684953A1 Use of s1p receptor modulator
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990053A1 Pharmaceutical composition for enhancing adiponectin production
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1989210A2 A2a adenosine receptor antagonists
11/12/2008EP1989192A2 1,3-dioxane carboxylic acids
11/12/2008EP1988923A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist
11/12/2008EP1988888A2 Use of dha and ara in the preparation of a composition for preventing or treating obesity
11/12/2008EP1988885A2 Combination of organic compounds
11/12/2008EP1844029B1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents
11/12/2008EP1658067B1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
11/12/2008EP1606282B1 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
11/12/2008EP1478659B1 Biologically active peptides
11/12/2008EP1424894B1 Inhibition of pathological angiogenesis in vivo
11/12/2008EP1409468B1 Guanidinobenzamides as mc4-r agonists
11/12/2008EP1365771B9 Method of treating certain eye diseases
11/12/2008EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists
11/12/2008EP1083930B1 Insulin supplemented infant formula
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305009A Aza-substituted spiro derivative
11/12/2008CN101304993A Compounds and compositions as ppar modulators
11/12/2008CN101304992A 1, 3-disubstituted indole derivatives for use as PPAR modulators
11/12/2008CN101304984A Oxazole and thiazole ppar modulator
11/12/2008CN101304979A Quinazoline derivative and pharmaceutical
11/12/2008CN101304737A Diaryl urea for treating diabetic neuropathy
11/12/2008CN101304654A Human G protein-coupled receptor and modulators thereof for the treatment of obesity and conditions related thereto
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302246A Melanin cortical hormone receptor heptapeptide excitant, preparation and use thereof
11/12/2008CN101302245A Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/12/2008CN101302215A 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione,maleic acid salt,hydrate as pharmaceutical
11/12/2008CN101302171A Production process of pure amino acid chelate and use thereof
11/12/2008CN101301455A Chinese medicine compound turmeric rhizome solid dispersion for treating hyperlipemia
11/12/2008CN101301429A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301425A Formulation for treating diabetes and promoting coronary circulation and quality control method
11/12/2008CN101301424A Chinese medicine composition for treating diabetes and method for preparing the same
11/12/2008CN101301413A Cordyceps sinensis and Rhodiola rosea capsules and preparation thereof
11/12/2008CN101301402A Nutrition health care replenisher for reinforcing reproduction performance of boar
11/12/2008CN101301401A Camellia effective ingredients and extracting method and use thereof
11/12/2008CN101301386A Oral liquid of Wuqingtongti and preparation thereof
11/12/2008CN101301374A Preparation of loquat leaf total flavones and functions thereof for reducing blood sugar and blood fat
11/12/2008CN101301335A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301334A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301333A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301332A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301329A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof
11/12/2008CN101301327A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301326A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301325A Pharmaceutical combination for preventing birth-defect and improving memory
11/12/2008CN101301319A Preparation of granada flower polyphenol and uses thereof
11/12/2008CN101301317A Compound abalone shell calcium tablet
11/12/2008CN101301314A Technique for producing liver extract
11/12/2008CN101301311A Potassium magnessium aspartape sterilized powder injection and preparation thereof
11/12/2008CN101301309A Further novel forms of interfering RNA molecules
11/12/2008CN101301298A Hyperlipemia prophylactic and therapeutic agent
11/12/2008CN101301294A Combinated inhibitors of FBP-ase and antidiabetic agents for diabetes treatment
11/12/2008CN101301293A Acidum folicum effervescent tablet and preparation thereof
11/12/2008CN101301285A Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
11/12/2008CN101301087A Method for extracting soluble calcium citrate using potato slag
11/12/2008CN101301081A Horseradish tree chawing tablet
11/12/2008CN101301071A Battercake for reducing blood sugar and method of processing the same
11/12/2008CN101301015A Composite mulberry leaf tea
11/12/2008CN100432077C N-sulfonylaminothiazole
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432056C Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100431582C Extraction process of aloe gel concentrate
11/12/2008CN100431571C Oral Chinese medicine preparation for replenishing vitamins and trace elements
11/12/2008CN100431560C Alcohol in use for reducing blood fat and lowering the blood pressure
11/12/2008CN100431554C A method for preparing silkworm powder
11/12/2008CN100431540C Treatment of diabetes with thiazolidinedione and metformin
11/12/2008CN100431529C Soft capsule for reducing blood fat and its preparing method
11/12/2008CN100431434C Soft drink replacer
11/11/2008US7449560 Phosophoinositoglycan binding proteins
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc.
11/11/2008US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones
11/11/2008US7449482 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/11/2008US7449185 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders
11/10/2008CA2588491A1 Composition and method for increasing the metabolism of free fatty acids and facilitating a favorable blood lipid profile
11/10/2008CA2588436A1 Composition and method for inducing lipolysis and increasing the metabolism of free fatty acids
11/06/2008WO2008134693A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/06/2008WO2008134690A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme